Enhanced antibody half-life improves in vivo activityJonathan Zalevsky, John R. Desjarlais, Greg A. Lazar et al.|Nature Biotechnology|2010Cited by 654
Antibody-Mediated Coengagement of FcγRIIb and B Cell Receptor Complex Suppresses Humoral Immunity in Systemic Lupus ErythematosusHolly M. Horton, David E. Szymkowski, Seung Y. Chu et al.|The Journal of Immunology|2011Cited by 144
XmAb™2513, an Fc Engineered Humanized Anti-CD30 Monoclonal Antibody, Has Potent In Vitro and In Vivo Activities, and Has the Potential for Treating Hematologic Malignancies.Chris E. Lawrence, David F. Carmichael, John R. Desjarlais et al.|Blood|2007Cited by 11